{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: In contrast to nifedipine , CD - 832 ( 10 micrograms / kg / min ) prevented the decrease in percentage segmental shortening from 32 + / - 12 % to 115 + / - 26 % of the control value ( P < . 01 ) and ST - segment elevation from 5 . 6 + / - 1 . 0 mV to 1 . 6 + / - 1 . 3 mV ( P < . 01 ) at 3 min after ISO infusion with stenosis .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| ISO |\n\nExplanation:\n\nIn this paragraph, the \"Disease\" entities refer to medical conditions or abnormalities. The only disease mentioned in the text is \"ISO\", which is short for isoproterenol, a medication that can cause symptoms similar to those of a heart attack when given in high doses."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| ISO |\n\nExplanation:\n\nIn this paragraph, the only disease mentioned is \"ISO\", which is short for isoproterenol. While \"stenosis\" refers to a narrowing or constriction of a blood vessel or other tubular organ, it is not a disease itself but rather a symptom or manifestation of an underlying disease. Therefore, it is not included in the table."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: In contrast to nifedipine , CD - 832 ( 10 micrograms / kg / min ) prevented the decrease in percentage segmental shortening from 32 + / - 12 % to 115 + / - 26 % of the control value ( P < . 01 ) and ST - segment elevation from 5 . 6 + / - 1 . 0 mV to 1 . 6 + / - 1 . 3 mV ( P < . 01 ) at 3 min after ISO infusion with stenosis .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| nifedipine |\n| CD - 832 |\n| 10 micrograms / kg / min |\n| control value |\n| ISO |\n| stenosis |\n\nExplanation:\n\n1. nifedipine\n2. CD - 8"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| nifedipine |\n| CD - 832 |\n| ISO |\n\nExplanation:\n\n1. nifedipine\n2. CD - 832\n3. ISO - Isoproterenol (a medication that is often referred to by its abbreviation \"ISO\")"}
  ]
}